Yahoo Poland Wyszukiwanie w Internecie

Search results

1. www.nature.com › articles › s41598/024/65815-6Comparison of the efficacy and safety of SCD411 and reference ......

   www.nature.com › articles › s41598/024/65815-6

   26 cze 2024 · In conclusion, SCD411 has equivalent efficacy compared with reference aflibercept in patients with neovascular age-related macular degeneration and has a comparable safety profile. The results ...

2. eyewire.news › news › lumithera-announces-us-lightsite-iii-clinical-trial-meetsLumiThera Announces US LIGHTSITE III Clinical Trial Meets ... -...

   eyewire.news › news › lumithera-announces-us-lightsite-iii-clinical-trial-meets

   • Zapisane w pamięci cache

   6 dni temu · LumiThera announced positive findings in its LIGHTSITE III multicenter clinical trial in non-neovascular (dry) age-related macular degeneration (AMD) subjects treated with the Valeda Light Delivery System.

3. mivision.com.au › 2023 › 03Sustained Vision Improvements from Valeda Light Delivery System

   mivision.com.au › 2023 › 03

   • Zapisane w pamięci cache

   2 lip 2024 · Medical device company LumiThera Inc. said data from its LIGHTSITE III clinical trial demonstrated sustained vision improvement in early and intermediate age-related macular degeneration (AMD) subjects treated with the Valeda Light Delivery System.

4. www.tandfonline.com › doi › fullFull article: Photobiomodulation (PBM) therapy: emerging data and...

   www.tandfonline.com › doi › full

   29 cze 2024 · PBM as a routine clinical therapy option in non-neovascular AMD was introduced by LumiThera with the VALEDA Device in 2018. Since then, more than 20.000 patients with non-neovascular AMD/GA have been treated with VALEDA in Europe and South America.

5. eyewire.news › tv › a-rewarding-experienceA Rewarding Experience - Eyewire+

   eyewire.news › tv › a-rewarding-experience

   • Zapisane w pamięci cache

   6 dni temu · LumiThera Shares New Data for Dry AMD Patients Treated with PBM Using the Valeda System

6. mivision.com.au › 2018 › 07LumiThera LT-300 Granted CE For Dry AMD - mivision

   mivision.com.au › 2018 › 07

   • Zapisane w pamięci cache

   2 lip 2024 · Patients with dry age related macular degeneration (dry AMD) may be one step closer to a treatment that may improve visual outcomes, following awarding of a CE mark for an LT-300 light delivery system developed by American company LumiThera.

7. www.reuters.com › world › germanyGermany News | Latest Headlines & Stories | Reuters

   www.reuters.com › world › germany

   3 dni temu · Reuters.com is your online source for the latest Europe news stories and current events, ensuring our readers up to date with any breaking news developments